001     120198
005     20240228135017.0
024 7 _ |a 10.1038/nm.3666
|2 doi
024 7 _ |a pmid:25150496
|2 pmid
024 7 _ |a pmc:PMC4334261
|2 pmc
024 7 _ |a 1078-8956
|2 ISSN
024 7 _ |a 1546-170X
|2 ISSN
024 7 _ |a altmetric:2632651
|2 altmetric
037 _ _ |a DKFZ-2017-00780
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a He, Xuelian
|b 0
245 _ _ |a The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.
260 _ _ |a New York, NY
|c 2014
|b Nature America Inc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1491476353_16890
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Medulloblastoma, the most common malignant childhood brain tumor, exhibits distinct molecular subtypes and cellular origins. Genetic alterations driving medulloblastoma initiation and progression remain poorly understood. Herein, we identify GNAS, encoding the G protein Gαs, as a potent tumor suppressor gene that, when expressed at low levels, defines a subset of aggressive Sonic hedgehog (SHH)-driven human medulloblastomas. Ablation of the single Gnas gene in anatomically distinct progenitors in mice is sufficient to induce Shh-associated medulloblastomas, which recapitulate their human counterparts. Gαs is highly enriched at the primary cilium of granule neuron precursors and suppresses Shh signaling by regulating both the cAMP-dependent pathway and ciliary trafficking of Hedgehog pathway components. Elevation in levels of a Gαs effector, cAMP, effectively inhibits tumor cell proliferation and progression in Gnas-ablated mice. Thus, our gain- and loss-of-function studies identify a previously unrecognized tumor suppressor function for Gαs that can be found consistently across Shh-group medulloblastomas of disparate cellular and anatomical origins, highlighting G protein modulation as a potential therapeutic avenue.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Hedgehog Proteins
|2 NLM Chemicals
650 _ 7 |a Cyclic AMP
|0 E0399OZS9N
|2 NLM Chemicals
650 _ 7 |a GTP-Binding Protein alpha Subunits, Gs
|0 EC 3.6.5.1
|2 NLM Chemicals
700 1 _ |a Zhang, Liguo
|b 1
700 1 _ |a Chen, Ying
|b 2
700 1 _ |a Remke, Marc
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Shih, David
|b 4
700 1 _ |a Lu, Fanghui
|b 5
700 1 _ |a Wang, Haibo
|b 6
700 1 _ |a Deng, Yaqi
|b 7
700 1 _ |a Yu, Yang
|b 8
700 1 _ |a Xia, Yong
|b 9
700 1 _ |a Wu, Xiaochong
|b 10
700 1 _ |a Ramaswamy, Vijay
|b 11
700 1 _ |a Hu, Tom
|b 12
700 1 _ |a Wang, Fan
|b 13
700 1 _ |a Zhou, Wenhao
|b 14
700 1 _ |a Burns, Dennis K
|b 15
700 1 _ |a Kim, Se Hoon
|0 0000-0001-7516-7372
|b 16
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 17
|u dkfz
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 18
|u dkfz
700 1 _ |a Weinstein, Lee S
|b 19
700 1 _ |a Pomeroy, Scott L
|b 20
700 1 _ |a Gilbertson, Richard J
|b 21
700 1 _ |a Rubin, Joshua B
|b 22
700 1 _ |a Hou, Yiping
|b 23
700 1 _ |a Wechsler-Reya, Robert
|b 24
700 1 _ |a Taylor, Michael D
|b 25
700 1 _ |a Lu, Q Richard
|b 26
773 _ _ |a 10.1038/nm.3666
|g Vol. 20, no. 9, p. 1035 - 1042
|0 PERI:(DE-600)1484517-9
|n 9
|p 1035 - 1042
|t Nature medicine
|v 20
|y 2014
|x 1546-170X
909 C O |o oai:inrepo02.dkfz.de:120198
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2014
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT MED : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT MED : 2015
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21